Use of metabolic positron emission tomography/computed tomography in patients with locally advanced invasive breast carcinomas
Summary. Current study presents retrospective analysis of performing positron emission tomography/computed tomography (PET/CT) in patients with locally advanced invasive ductal breast carcinoma, first of all, in order to assess distant metastasis in patients without clinical evidence of systemic spread. Substantial amount of such patients (around 30%) showed PET/CT evidence of subsequently proven metastatic disease. Utilizing this imaging modality in abovementioned patient cohort impacts patient management due to upstaging and provides baseline metabolic data for monitoring and response assessment.
Leave a comment